Home › Kanser sa Ovary › Ohio › Toledo
Pag-aaral pangklinika para sa Kanser sa Ovary sa Toledo, OH
Isang pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Toledo. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi ang layo
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Nagre-recruitPhase 1
- Site 06, Maumee · 9 mi ang layo
DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
- Research Site, Maumee · 9 mi ang layo
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Nagre-recruitPhase 3
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Nagre-recruitPhase 3
- Promedica Flower Hospital, Sylvania · 9 mi ang layo
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- Toledo Clinic Cancer Center, Toledo
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Nagre-recruitPhase 3
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Nagre-recruitPhase 1
- Normunity Investigational Site, Maumee · 9 mi ang layo
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Nagre-recruit
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- ProMedica Flower Hospital, Sylvania · 9 mi ang layo
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Taylor Cancer Research Center, Maumee · 9 mi ang layo
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- Taylor Cancer Research Center, Maumee · 9 mi ang layo
Pag-aaral para sa Kanser sa Ovary sa ibang lungsod
- Houston, TX89 pag-aaral
- New York City, NY69 pag-aaral
- Boston, MA61 pag-aaral
- Los Angeles, CA50 pag-aaral
- Nashville, TN49 pag-aaral
- Arlington, VA46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Columbus, OH39 pag-aaral
- St. Louis, MO38 pag-aaral
- Chicago, IL36 pag-aaral
- San Antonio, TX31 pag-aaral
- Cleveland, OH30 pag-aaral
Iba pang pag-aaral sa Toledo
- Non-Small Cell Lung Cancer17 pag-aaral
- Kanser sa Baga11 pag-aaral
- Metastatic Cancer10 pag-aaral
- Stroke9 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg8 pag-aaral
- Kanser ng Endometrium8 pag-aaral
- Melanoma8 pag-aaral
- Kanser sa Pancreas8 pag-aaral
- Kanser sa Prostate7 pag-aaral
- Kanser sa Esophagus7 pag-aaral
- Ischemic Stroke7 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.